Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;2(4):283-6.
doi: 10.5847/wjem.j.1920-8642.2011.04.007.

Artificial liver support system in treatment of liver failure after acute poisoning

Affiliations

Artificial liver support system in treatment of liver failure after acute poisoning

Li-Gang Chen et al. World J Emerg Med. 2011.

Abstract

Background: Acute poisoning (AP) may cause failure of the liver and kidney, and even death. This study aimed to investigate the efficacy of artificial liver support system (ALSS) on the treatment of liver failure after acute poisoning.

Methods: A total of 31 patients with liver failure caused by AP were admitted to emergency ICU, central ICU, and Department of Gastroenterology from 2005 to 2009 in Zhongshan Hospital Affiliated to Xiamen University, China. Among them, 13 patients served as a treatment group, and used ALSS in addition to detoxification treatment and protective treatment of liver function, and the other 18 patients served as a control group receiving detoxification treatment and protective treatment of liver function.

Results: In the treatment group, 10 patients (76.9%) were cured or improved, 2 died, and 1 was discharged against advice. In the 18 patients in the control group, 7 (38.9%) were cured or improved, 3 died, and 8 were discharged against advice. There was a significant difference in the rates of improvement between the two groups (P<0.05).

Conclusion: ALSS is a safe and effective clinical method for the treatment of acute toxic liver failure.

Keywords: Artificial liver support system; Liver failure; Toxicity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Li B, Xin S, Xing H, Zhao J, Zou Z, Zhang B, et al. Treatment of severe viral hepatitis with artificial liver support system. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002;16:157–159. - PubMed
    1. Qian Y, Lanjuan L, Jianrong H, Jun L, Hongcui C, Suzhen F, et al. Study of severe hepatitis treated with a hybrid artificial liver support system. Int J Artif Organs. 2003;26:507–513. - PubMed
    1. Zhu YG, Zhang YY, Lu H, Gao JH, Gu JL. A clinical study of severe hepatitis treated with a partial plasma exchange artificial liver support system. Zhonghua Gan Zang Bing Za Zhi. 2006;14:616–617. - PubMed
    1. Aggarwal P, Handa R, Wali JP. Acute Poisoning-Management Guidelines. J Indian Acad Clin Med. 2004;5:142–147.
    1. Gan JH, Zhou XQ, Qin AL, Luo EP, Zhao WF, Yu H, et al. Hybrid artificial liver support system for treatment of severe liver failure. World J Gastroenterol. 2005;11:890–894. - PMC - PubMed

LinkOut - more resources